Torrent Pharma Board Meeting on 22-May-26

Torrent Pharmaceuticals intimated BSE/NSE of its Board meeting scheduled for 22-May-26.
The Board will consider audited FY26 results and a potential final dividend recommendation.
Enabling resolutions for fundraising via QIP, convertible instruments, or other modes are also on the agenda.